EP 2321
Alternative Names: EP23.21Latest Information Update: 16 Jul 2016
At a glance
- Originator Europroteome
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Germany
- 12 Aug 2003 Preclinical trials in Cancer in Germany (unspecified route)